Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/72601
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Selective inhibition of biotin protein ligase from Staphylococcus aureus |
Author: | Soares da Costa, T. Tieu, W. Yap, M. Pendini, N. Polyak, S. Pedersen, D. Morona, R. Turnidge, J. Wallace, J. Wilce, M. Booker, G. Abell, A. |
Citation: | Journal of Biological Chemistry, 2012; 287(21):17823-17832 |
Publisher: | American Society for Biochemistry and Molecular Biology |
Issue Date: | 2012 |
ISSN: | 0021-9258 1083-351X |
Statement of Responsibility: | Tatiana P. Soares da Costa, William Tieu, Min Y. Yap, Nicole R. Pendini, Steven W. Polyak, Daniel Sejer Pedersen, Renato Morona, John D. Turnidge, John C. Wallace, Matthew C.J. Wilce, Grant W. Booker and Andrew D. Abell |
Abstract: | There is a well documented need to replenish the antibiotic pipeline with new agents to combat the rise of drug resistant bacteria. One strategy to combat resistance is to discover new chemical classes immune to current resistance mechanisms that inhibit essential metabolic enzymes. Many of the obvious drug targets that have no homologous isozyme in the human host have now been investigated. Bacterial drug targets that have a closely related human homologue represent a new frontier in antibiotic discovery. However, to avoid potential toxicity to the host, these inhibitors must have very high selectivity for the bacterial enzyme over the human homolog. We have demonstrated that the essential enzyme biotin protein ligase (BPL) from the clinically important pathogen Staphylococcus aureus could be selectively inhibited. Linking biotin to adenosine via a 1,2,3 triazole yielded the first BPL inhibitor selective for S. aureus BPL over the human equivalent. The synthesis of new biotin 1,2,3-triazole analogues using click chemistry yielded our most potent structure (Ki 90 nM) with a >1100-fold selectivity for the S. aureus BPL over the human homologue. X-ray crystallography confirmed the mechanism of inhibitor binding. Importantly, the inhibitor showed cytotoxicity against S. aureus but not cultured mammalian cells. The biotin 1,2,3-triazole provides a novel pharmacophore for future medicinal chemistry programs to develop this new antibiotic class. |
Keywords: | Cell Line Humans Staphylococcus aureus Triazoles Biotin Ligases Bacterial Proteins Enzyme Inhibitors Crystallography, X-Ray Drug Resistance, Bacterial Protein Binding Click Chemistry |
Rights: | © 2012 by The American Society for Biochemistry and Molecular Biology, Inc. |
DOI: | 10.1074/jbc.M112.356576 |
Published version: | http://dx.doi.org/10.1074/jbc.m112.356576 |
Appears in Collections: | Aurora harvest 2 Molecular and Biomedical Science publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.